Polyclonal Rabbit anti‑Human LIMK1 + LIMK2 Antibody (Asp402, IHC, WB) LS‑C176106
Polyclonal Rabbit anti‑Human LIMK1 + LIMK2 Antibody (Asp402, IHC, WB) LS‑C176106
Antibody:
LIMK1 + LIMK2 Rabbit anti-Human Polyclonal (Asp402) Antibody
Application:
IHC, IHC-P, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Overview
Antibody:
LIMK1 + LIMK2 Rabbit anti-Human Polyclonal (Asp402) Antibody
Application:
IHC, IHC-P, WB
Reactivity:
Human, Mouse, Rat
Format:
Unconjugated, Unmodified
Specifications
Description
LIMK1 + LIMK2 antibody LS-C176106 is an unconjugated rabbit polyclonal antibody to LIMK1 + LIMK2 (Asp402) from human. It is reactive with human, mouse and rat. Validated for IHC and WB.
Target
Human LIMK1 + LIMK2
Reactivity
Human, Mouse, Rat
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Immunogen
Synthetic peptide around Asp402 of human LIMK1/2 / LIM domain kinase 1/2
Specificity
Human LIMK1/2 / LIM domain kinase 1/2
Applications
- IHC
- IHC - Paraffin
- Western blot
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, pH 7.2, 0.05% Sodium Azide
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse, Rat, Bovine, Chicken
Applications:
Western blot
Reactivity:
Human
Range:
0.5-10 ng/ml
Species:
Mouse
Applications:
Flow Cytometry
Reactivity:
Range:
31.25-2000 ng/ml
Reactivity:
Mouse
Range:
15.6-1000 pg/ml
Reactivity:
Bovine
Range:
0.312-20 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 5/5/2024